Myth Check: Can a Laser Actually Erase Melasma?

Walk into almost any laser consultation in Beverly Hills and melasma will come up. The brown to gray-brown patches across the cheeks, forehead, and upper lip are stubborn, they photograph poorly, and they respond inconsistently to creams. So the appeal of a laser that simply "blasts the pigment away" is obvious. The problem is that melasma is not a pigment stain sitting passively in the skin. It is an active, hormonally and light-driven overproduction disorder, and that distinction changes everything about how lasers should, and should not, be used.

The myth: melasma is like a tattoo, and lasers remove tattoos. Tattoo ink is inert. Once a picosecond or Q-switched laser shatters ink particles, the immune system clears the fragments and they do not come back. Melasma pigment comes from melanocytes that are metabolically overactive. Studies of melasma skin consistently show upregulated melanocyte activity, increased vascularity in many patients, and a compromised basement membrane that lets pigment drop into the dermis. If a laser injures that skin aggressively, the melanocytes frequently respond the way they respond to any insult: by making more pigment. This is why high-fluence treatments can produce a clear face at week two and a darker, more confluent patch by month three, a pattern clinicians call rebound hyperpigmentation. For an independent overview, see Melasma and pigmentation: diagnosis and treatment.

Why heat is the enemy. Most laser complications in melasma trace back to bulk thermal injury. Melanin absorbs strongly across visible and near-infrared wavelengths, so any device that dumps significant heat into a melasma patch risks stimulating melanogenesis and inflaming the dermis. Inflammation activates signaling pathways, including those involving stem cell factor and endothelin, that push melanocytes to produce more melanin. Ablative fractional CO2 resurfacing, aggressive IPL, and high-energy 532 nm treatments all carry this risk in melasma-prone skin, particularly in Fitzpatrick types III to VI, which represent a large share of the Southern California patient population.

What actually has mechanistic support. The devices with the best track record in melasma share one theme: minimal heat, subthreshold energy, and repetition. Low-fluence 1064 nm Q-switched Nd:YAG, often marketed as "laser toning," uses fluences well below the threshold that destroys melanocytes. The proposed mechanism is subcellular photothermolysis: melanosomes inside the melanocyte are fragmented while the cell itself survives, temporarily reducing pigment output without triggering a wound response. Picosecond lasers at 1064 nm or 755 nm, delivered through fractionated or diffractive lens arrays at low energies, work on a similar logic with even shorter pulse durations, meaning more photoacoustic effect and less heat per pulse. Nonablative fractional 1927 nm thulium lasers take a different route, creating microscopic columns of injury in the very superficial epidermis that shuttle pigment out through the stratum corneum while leaving most tissue untouched. All three approaches typically require a series of sessions, commonly four to eight, spaced weeks apart.

Even the right laser is not a cure. This is the part that gets lost in marketing. Controlled studies of laser toning show meaningful lightening during treatment, followed by frequent recurrence within months once sessions stop, because the underlying drivers remain: estrogen and progesterone signaling, ultraviolet exposure, and increasingly recognized visible light exposure, especially blue light, which stimulates pigment in darker skin types through the opsin 3 receptor. A laser can clear the warehouse, but it does not fire the workers. Sustained results depend on suppressing production, which is why experienced practitioners pair any device work with tinted mineral sunscreen containing iron oxides, which block visible light, plus topical agents such as hydroquinone, azelaic acid, cysteamine, or tranexamic acid. Oral tranexamic acid, prescribed off label in appropriate candidates, has some of the strongest adjunct data, likely by dampening the plasmin pathway that links UV exposure to melanocyte stimulation.

Red flags in a consultation. Be cautious if a provider promises permanent melasma removal in one or two sessions, recommends IPL as a first-line melasma treatment without discussing rebound risk, does not ask about pregnancy, hormonal contraception, or medication history, or skips a Wood's lamp or dermoscopic assessment to gauge pigment depth. Dermal-predominant melasma responds poorly to almost everything, and honest clinicians will say so.

The bottom line. Lasers have a legitimate role in melasma, but as one instrument in a maintenance program, not as an eraser. The devices that help are deliberately gentle, the schedule is long, and the results require ongoing photoprotection and topicals to hold. In a market as saturated with devices as Beverly Hills, the most valuable thing a patient can bring to a consultation is the understanding that with melasma, less energy, more sessions, and realistic expectations consistently beat the promise of a single dramatic fix.

Related reading: Can Laser Make Melasma Worse? A Myth Check.